The AKT-mTOR axis regulates de novo differentiation of CD4 +Foxp3+ cells

644Citations
Citations of this article
330Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

CD4+Foxp3+ regulatory T (T reg) cells play an essential role in maintaining immunological tolerance via their suppressive function on conventional CD4+ T (Tconv) cells. Repertoire studies suggest that distinct T cell receptor signaling pathways lead to T reg differentiation, but the signals that regulate T reg specification are largely unknown. We identify AKT as a strong repressor of entry into the T reg phenotype in vitro and in vivo. A constitutively active allele of AKT substantially diminished TGF-β-induced Foxp3 expression in a kinase-dependent manner and via a rapamycin-sensitive pathway, implicating the AKT-mamalian target of rapamycin axis. The observed impairment in Foxp3 induction was part of a broad dampening of the typical T reg transcriptional signature. Expression of active AKT at a stage before Foxp3 turn on during normal T reg differentiation in the thymus selectively impaired differentiation of CD4+Foxp3+ cells without any alteration in the positive selection of Tconv. Activated AKT, in contrast, did not affect established Foxp3 expression in T reg cells. These results place AKT at a nexus of signaling pathways whose proper activation has a strong and broad impact on the onset of T reg specification. JEM © The Rockefeller University Press.

Cite

CITATION STYLE

APA

Haxhinasto, S., Mathis, D., & Benoist, C. (2008). The AKT-mTOR axis regulates de novo differentiation of CD4 +Foxp3+ cells. Journal of Experimental Medicine, 205(3), 565–574. https://doi.org/10.1084/jem.20071477

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free